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Background: Targeted genomic enrichment (TGE) is a widely used method for isolating and enriching specific
genomic regions prior to massively parallel sequencing. To make effective use of sequencer output, barcoding and
sample pooling (multiplexing) after TGE and prior to sequencing (post-capture multiplexing) has become routine.
While previous reports have indicated that multiplexing prior to capture (pre-capture multiplexing) is feasible, no
thorough examination of the effect of this method has been completed on a large number of samples. Here we
compare standard post-capture TGE to two levels of pre-capture multiplexing: 12 or 16 samples per pool. We
evaluated these methods using standard TGE metrics and determined the ability to identify several classes of
genetic mutations in three sets of 96 samples, including 48 controls. Our overall goal was to maximize cost
reduction and minimize experimental time while maintaining a high percentage of reads on target and a high
depth of coverage at thresholds required for variant detection.
Results: We adapted the standard post-capture TGE method for pre-capture TGE with several protocol
modifications, including redesign of blocking oligonucleotides and optimization of enzymatic and amplification
steps. Pre-capture multiplexing reduced costs for TGE by at least 38% and significantly reduced hands-on time
during the TGE protocol. We found that pre-capture multiplexing reduced capture efficiency by 23 or 31% for
pre-capture pools of 12 and 16, respectively. However efficiency losses at this step can be compensated by
reducing the number of simultaneously sequenced samples. Pre-capture multiplexing and post-capture TGE
performed similarly with respect to variant detection of positive control mutations. In addition, we detected no
instances of sample switching due to aberrant barcode identification.
Conclusions: Pre-capture multiplexing improves efficiency of TGE experiments with respect to hands-on time and
reagent use compared to standard post-capture TGE. A decrease in capture efficiency is observed when using
pre-capture multiplexing; however, it does not negatively impact variant detection and can be accommodated by
the experimental design.
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Massively parallel sequencing has expanded the genomics
era by dramatically reducing the cost and time of large-
scale DNA sequencing. Although whole genome sequen-
cing may soon become routine, in terms of cost, time,
and labor, it is often more practical to target specific
regions of interest in the genome. Targeted genomic
enrichment (TGE), also known as targeted sequence cap-
ture, allows efficient isolation of genomic regions prior to
massively parallel sequencing [1]. Briefly, DNA libraries
are hybridized with DNA or RNA oligonucleotides com-
plementary to regions of interest (baits), and these bait-
library complexes are pulled out of solution after the
hybridization to generate an enriched library for se-
quencing. This method has generally been used to target
exonic and splice-site sequences of the human genome,
as ~ 85% of known mutations reside in these regions [2].
TGE has been used to discover mutations in sets of
genes associated with specific diseases [3-5] or, in an un-
biased way, by targeting the whole exome [2]. A trade-off
exists between the number of base-pairs targeted for
sequencing and the throughput of sequencing with respect
to cost and time. However, in all types of TGE, there is
increased efficiency in uncovering disease-causing muta-
tions when compared to whole genome sequencing.
The increase in sequencer output has well outpaced our
ability to efficiently use the sequence generated. While
it is clear that saturating levels of sequencing coverage
are required for the lowest false positive and false
negative rates in TGE experiments [6], it is also clear
that there is a diminishing return after the threshold
coverage level for variant detection is exceeded, and, in
fact, over-coverage can introduce errors [7]. Pooling
samples is an attractive option to maximize sequencer
output; however, due to sequencer error rate, reliable
differentiation of true positives from false positives is
generally difficult [8] unless specialized software is
employed [9,10]. To avoid this difficulty, molecular bar-
codes (indexes) can be ligated to sheared DNA fragments
prior to pooling in a process called multiplexing. Because
the purpose of TGE is to focus on relatively small gen-
omic regions of interest, multiplexing can be used to
maximize sequencer output.
When applied to TGE, multiplexing can be performed
prior to capture (pre-capture multiplexing) or after cap-
ture (post-capture multiplexing). The first protocols
using molecular barcodes employed a post-capture ap-
proach [11] and post-capture multiplexing has since
become the standard method for TGE. Several studies,
however, have shown that the pre-capture approach is
also feasible and that this method offers three important
advantages over post-capture multiplexing: 1) decreased
cost as the capture step is generally the most costly step
in the TGE protocol; 2) reduced hands-on time as samplesare pooled earlier in the protocol; and, 3) reduced cross-
contamination risk by the earlier addition barcodes
[12-15].
However, the limits of pre-capture multiplexing have
not been thoroughly tested. Of two pilot studies show-
ing the feasibility of pre-capture multiplexing one used
8 samples and single pools of 3 or 5 samples pooled
pre-capture [12], while another used 9 samples with single
pools of either 3 or 9 samples pooled pre-capture [13].
Both of these studies included only 1 pool at each pool-
ing size and so a detailed comparison of the effects of
increasing pool size and a comparison to standard post-
capture pooling was not possible. In another study,
pre-capture pools of 4, 6, and 12 were evaluated and the
authors went on to use 6 pools of 8 samples to sequence
48 samples [14]. And finally, in another study the authors
pooled 20 samples pre-capture, however, only a single
pool was used and micro-array based TGE was used [15].
All of these studies showed the feasibility of pre-capture
pooling for solution-phase TGE, however we sought to
study the effects of pre-capture pooling on TGE in a sys-
tematic fashion in different pool sizes on a large number
of samples.
In general, post-capture multiplexing is used for TGE
whereas pre-capture multiplexing is not. In this study,
we sought to address several questions germane to multi-
plexing during TGE experiments, including the effect
of inter-sample competition for capture baits during
hybridization, the impact on capture efficiency, and the
downstream effects on overall sequence quality as mea-
sured by read mapping and duplicate reads. To address
these questions, we compared standard post-capture
multiplexing to pre-capture multiplexing using two pool
sizes (n=12 or 16 samples per pool) to study a large set
of samples (n = 96). We demonstrate the significant
advantages of pre-capture multiplexing in cost and time
reductions while at the same time maintaining our
minimum threshold for accurate variant detection.
Results
We compared standard post-capture multiplexing with
pre-capture multiplexing for TGE of a relatively small
genomic region of 521,647 bp that comprises all known
non-syndromic deafness and Usher syndrome genes as
described previously [3]. We performed TGE on a set of
96 DNA samples: 48 unknowns, 39 positive controls
with 44 Sanger-sequence-verified deafness-causing muta-
tions, and 9 negative controls. The samples were cap-
tured in two ways for comparison, as shown in Figure 1.
(1) 96 samples were prepared using standard post-capture
multiplexing TGE and run in a single Illumina HiSeq lane
(post-capture 96) and (2) pools of 12 or 16 (pre-capture
12 and pre-capture 16) samples were pre-capture multi-
plexed with barcodes added during ligation and sequenced
Figure 1 Experimental design showing pertinent steps in the TGE protocol including the indexing PCR during which barcodes are
incorporated into separate DNA libraries. A) standard post-capture TGE, 96 captures are required as barcodes are incorporated during second
PCR after capture and prior to sequencing, B) pre-capture multiplexing with pools of 12 (pre-capture 12a and pre-capture 12b), 8 captures
required as barcodes are incorporated when adaptors are ligated prior to the first PCR and capture, and C) pre-capture multiplexing with pools of
16 (pre-capture 16), 6 captures required.
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12 samples for pre-capture 12; 6 pools of 16 samples for
pre-capture 16). TGE for post-capture samples was per-
formed with the Agilent SureSelect XT version 1 protocol
while TGE for pre-capture samples was performed with
the Agilent SureSelect XT version 2, a protocol optimized
for pre-capture pooling with regards to hybridization,
amplification and capture wash conditions (see Methods).
A single sample in the post-capture 96 set failed sequen-
cing QC and was excluded from further analysis.
Total reads and read mapping
The total number of sequencing reads was significantly
lower in pre-capture lanes as compared with the post-
capture lane (Tukey’s post-hoc ANOVA p=0.004 and
p=0.02 for pre-capture 12 and pre-capture 16, respect-
ively), however, the two pre-capture lanes were not signifi-
cantly different. 97.4%, 93.3%, and 91.6% of sequencing
reads mapped on average for post-capture, pre-capture 12,
and pre-capture 16, respectively (Figure 2A). The percent
of mapped reads was significantly lower for pre-capture
lanes (independent samples T-test p < 0.01 for both pre-
capture 12 and 16), however in all cases, greater than
90% of reads mapped, constituting a high-quality sequen-
cing run in our experience.
Capture efficiency and duplicate reads
We define capture efficiency as the percent of all
mapped reads that overlap the targeted regions. In ourexperience using SureSelect TGE, capture efficiency
ranges from ~40% for small target regions (<200kb) to
up to ~80% for large target regions (50 Mb, i.e. the
exome) when using standard post-capture multiplexing
(data not shown). On average, the capture efficiency
for post-capture samples was 68.7% (Figure 2B). This
was significantly higher (p < 0.01) than the average for
both pre-capture 12 samples (45.3%) and pre-capture
16 samples (37.1%). The difference between pre-capture
12 and pre-capture 16 was also significantly different
(p < 0.01). The difference in average duplicate reads and
average optical duplicate reads also varied significantly
between all three methods (p < 0.01 in all cases) as
shown in Figure 2C, and was 12.6% versus 4.7% (post-
capture), 7.1% versus 1.8% (pre-capture 12), and 5.8%
versus 1.5% (pre-capture 16), respectively.
Coverage performance
Depth of coverage represents the number of sequencing
reads aligned over a sequenced base pair. On average,
all methods of multiplexing showed a 1X coverage
(Figure 3A) that was not significantly different: an aver-
age of 99.8%, 99.6%, and 99.4% for post-capture, pre-
capture 12, and pre-capture 16, respectively. 10X depth
of coverage (Figure 3A) was greater than 94% with all
methods of multiplexing, but lowest for pre-capture 16
(97.4%, 96.9%, and 94.9% for post-capture, pre-capture
12, and pre-capture 16, respectively). The average depth
of coverage for pre-capture 16 samples was significantly
Figure 2 Sequencing performance. Average results for 96 samples run in a single lane using different multiplexing methods. Bars show
standard error from the mean. A) Average percent of reads mapped to the reference human genome using BWA per multiplexing method, B)
Average capture efficiency, as defined by the percentage of mapped sequencing reads overlapping targeted intervals, and C) Average percent of
all reads identified as duplicates and optical duplicates by Picard tools. * p < 0.01 (independent samples T-test).
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pre-capture 12 (p < 0.01 in all cases). Average depth of
coverage (Figure 3B) was significantly reduced for pre-
capture 12 (average = 196) and pre-capture 16 (average =
136) samples when compared with post-capture samples
(average = 227) (p < 0.01 in all cases).
We found a difference in coverage distribution among
multiplexing methods (Figure 4). The distribution of
coverage for post-capture multiplexing was most broadly
distributed with increasingly sharply peaked distributionFigure 3 Targeted region coverage statistics. Average results for 96 sam
show standard error from the mean. Dashed boxes show simulated data fo
per lane. A) Coverage at 1X, 10X, and 20X, and B) Mean depth of coverageseen for pre-capture 12 and pre-capture 16 multiplexing.
We identified no systematic differences in coverage of
targeted regions that could not be accounted for by dif-
ferences in total numbers of reads when comparing dif-
ferent methods of multiplexing.
In order to obtain a similar depth of coverage as post-
capture samples when performing pre-capture 16 multi-
plexing, fewer pools of 16 can be sequenced in a single
lane as a compensation for reduced capture efficiency. To
test this hypothesis, we randomly sub-sampled sequencingples run in a single lane using different multiplexing methods. Bars
r pre-capture 16 (see Results) in varying decreasing numbers of pools
. * p < 0.01 (Independent samples T-test).
Figure 4 Comparison of frequency histograms for average depth of coverage for each multiplexing method. Histograms show the
average depth of coverage results for 96 samples run in a single lane using different multiplexing methods with normal curve in blue.
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of 5, 4, and 3 pools of 16 samples (80, 64, and 48 samples,
respectively) per lane (Figure 3A and B). We validated
this simulation technique by simulating data for 6 pools
of 16 and found results were not significantly different
when compared to actual data: average depth of coverage
was 125X and 136X for simulated and actual data, respect-
ively; coverage at 1X, 10X, and 20X was 99.5%, 96.5%, and
89.8% for simulated data and 99.7%, 94.9%, and 87.0%
for actual data. Our simulations for fewer number of
pools per lane showed that coverage levels approached
post-capture averages when reduced by a single pool:
coverage for 80 samples in 5 pools of 16 (80/5) was
99.7% at 1X, 97.6% at 10X and 92.6% at 20X (Figure 3).
When the number of pools was further reduced, results
surpassed post-capture averages.Variant detection
We used 96 unique DNA samples in three sets of 96
captures each. In each set of samples, 48 samples were
from persons with presumed genetic hearing loss of an
unknown cause and the results from these samples will
be reported elsewhere. 48 samples in each set were either
positive controls carrying deafness-causing mutations
verified by Sanger sequencing or negative controls
(Additional file 1: Table S1 and Additional file 2: Table S2).
The exact composition of samples per set was different be-
tween post-capture and pre-capture sets due to sample lim-
itations, but there was a similar composition of types of
control mutations in each set. The post-capture positive
control samples included 43 mutations: 5 small deletions,
2 large deletions, 27 missense mutations (34 heterozy-
gous and 4 homozygous), 4 mitochondrial mutations,
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pre-capture multiplexing lanes contained the same 44
positive control mutations: 3 small deletions, 2 large
deletions, 31 missense mutations (35 heterozygous and
2 homozygous), 6 mitochondrial mutations, and 3 splice
site mutations (all heterozygous).
The average number of variants identified within the
targeted regions of interest for post-capture, pre-capture
12, and pre-capture 16 samples was 601, 511, and 509
variants, respectively. When normalized by total number
of sequencing reads per sample, there was no significant
difference between methods (p = 0.642 and p = 0.677 for
post-capture compared with pre-capture 12 and pre-
capture 16, respectively). 100% of variants were iden-
tified in all three lanes using our variant calling and
annotation pipeline (see Methods) with the exception of
the sample from post-capture lane that failed at sequen-
cing (Additional file 1: Table S1 and Additional file 2:
Table S2). No pathogenic variants were identified in the
negative controls. We examined allelic balance for het-
erozygous positive control variants and found no signifi-
cant difference between post-capture, pre-capture 12, or
pre-capture 16 samples (variant reads/total reads aver-
age [standard deviation] was 0.48 [0.02], 0.47 [0.02],
0.47 [0.02], respectively).
We performed a systematic analysis to examine the
possibility of artifacts or sequencing errors associated
with molecular barcoding that may lead to erroneous
sample assignment (chimeras) and misdiagnosis. We
searched within each lane for positive control variants
present in the un-annotated (“raw”) variant call format
(VCF) files for any of the samples present in any other
sample in that lane even at low observation rates. We
did not find any evidence of sample-switching due to
aberrant barcode identification in any lanes, although
we did find that a single individual was an incidental
carrier for a disease-causing mutation in the MYO7A
gene (p.Ala397Asp), as this variant was found in all
three lanes and confirmed with Sanger sequencing.
Advantages of pre-capture multiplexing
Pre-capture multiplexing was associated with reduced
capture efficiency, which in turn reduced average depth
of coverage but did not negatively impact variant detec-
tion. Significant savings in cost and time were associated
with pre-capture multiplexing. Costs for XTv2 kits are
15% lower than XTv1. There are other costs that are
associated with library preparation including consumables
which are difficult to quantify, but can be estimated as
1/16th or 1/12th of the cost of post-capture TGE. As an
example, each SPRI-bead purification during the proto-
col costs approximately $5.76/purification. Using pre-
capture 16 multiplexing, samples are pooled for three of
these purifications compared to post-capture TGE. For96 samples, the cost simply for purification of each of
these samples individually three times (288 purifications,
as per the post-capture TGE method) is $1,658.88. Pre-
capture 16 multiplexing would reduce the number of
purifications required to 6 samples three times (18 purifi-
cations) and therefore the cost is $103.68 or a cost re-
duction of 93.75%. The same calculation yields a cost of
$138.24 for pre-capture 12 multiplexing and a corre-
sponding cost reduction of 91.7%. Similar reductions in
cost can be assumed for other reagents and consumables.
In our hands, TGE requires 6 hours for pre-
hybridization steps and 4 hours for post-hybridization
steps. Post-capture multiplexing introduces barcodes at
the final amplification step and pooling is completed im-
mediately prior to sequencing, which does not reduce
hands-on time. Pre-capture multiplexing occurs prior to
the hybridization and therefore 12X or 16X as many
samples can be hybridized and captured in the same
amount of time. Therefore, though difficult to quantify,
hands-on time is significantly reduced with pre-capture
multiplexing.
Discussion and conclusions
Massively parallel sequencing and TGE enable rapid and
efficient sequencing of hundreds of thousands or mil-
lions of base pairs of the human genome simultaneously.
While prices have decreased drastically, efficiency and
cost-effectiveness are still important considerations, es-
pecially when large numbers of samples are analyzed. In
this study we provide the first systematic comparison of
post- and pre-capture multiplexing on a large sample set.
We used a large number of positive control mutations
to validate this capture method, and in the process
uncovered a variety of genomic variants including small
and large deletions, and single nucleotide variants in con-
trol patients. We found no evidence of barcode switching
or erroneous barcode assignment. In addition, the allelic
balance, which is important for making heterozygous
calls, was not affected by pre-capture pooling.
As expected, our data show that multiplexing samples
prior to hybridization and capture reduces capture effi-
ciency. Importantly, we noted a decrease in duplicate
reads, which may partially offset this loss in efficiency.
We used simulations to show that reduced efficiency
can be compensated for by modifying the experimental
design (i.e. reducing the total number of pools sequenced
per lane). We hypothesize that this effect is due to com-
petition for complementary RNA baits among multiple
genomes, specifically because the effect was more pro-
nounced with the higher pool size (pre-capture 16). In
addition, we found a difference in coverage distribution
when comparing multiplexing methods (Figure 4), with
the distribution of coverage became less broad with
pre-capture pooling. We believe this effect also reflects
Shearer et al. BMC Genomics 2012, 13:618 Page 7 of 8
http://www.biomedcentral.com/1471-2164/13/618competition for baits with regions most deeply covered
becoming distributed amongst multiple genomes when
pre-capture multiplexing is used. Finally, we noted a
significant reduction in total number of reads and per-
cent of reads mapping. Because only 3 sequencing lanes
were compared, it was not possible to determine whether
this effect reflected inter-lane variability or the effects of
pre-capture multiplexing.
Costs are an important factor in any experimental
design. Kit costs for pre-capture multiplexing are 15%
lower. However, greater cost savings are found in the re-
duction in consumables and ancillary reagents used when
pre-capture multiplexing is employed. In our example,
we show that costs of purifications alone are reduced by
~94% for pre-capture 16 multiplexing and ~92% for pre-
capture 12 multiplexing. The most significant reduction
when using pre-capture multiplexing lies in reduced
hands-on time. Although this is difficult to quantify, 12X
or 16X as many samples can be processed after pooling
occurs when pre-capture multiplexing is used. Therefore,
due to the greatest reduction in costs and hands-on time,
as well as a lack of detrimental effects on quality of TGE,
pre-capture 16 represents the most effective and efficient
method for TGE of an experiment with a similar target
size as shown here (521,647 bp). When designing their own
experiments, investigators can estimate the optimum num-
ber of samples to pool pre-capture and sequence per lane
based on the effects on capture efficiency described here.
Here we show for the first time the effect of pre-
capture multiplexing during TGE on a large set of
samples. We noted a specific effect on capture efficiency
during pre-capture multiplexing and we hypothesize that
this effect is due to multiple genomes competing for
hybridization with complementary RNA. However, pre-
capture multiplexing provided significant cost-savings and
time reductions, resulted in no barcode mis-identification,
and could reliably identify several classes of genetic vari-
ation. In summary, pre-capture multiplexing increases
the efficiency of TGE and massively parallel sequencing
to identify genomic variants.
Methods
Samples
This study was approved by the University of Iowa
Institutional Review Board. We used 96 samples includ-
ing DNA from the following individuals: 39 positive
controls, 9 negative controls, and 48 unknowns. The
positive control individuals had non-syndromic hearing
loss (NSHL) and in total represented 44 mutations includ-
ing small indels, large deletions and missense mutations
previously diagnosed with Sanger sequencing (Additional
file 1: Table S1 and Additional file 2: Table S2). We used
9 unaffected individuals or HapMap samples as negative
controls. Due to sample quantities, the exact same setof control DNA could not be used twice. Instead, a
similar composition of genetic variants was assembled
to effectively compare post-capture and pre-capture multi-
plexing (Additional file 1: Table S1 and Additional file 2:
Table S2). The individuals with unknown causes of hear-
ing loss were enrolled in our large research study on
deafness and results will be reported elsewhere.
Targeted genomic enrichment and sequencing
We previously developed and reported our TGE platform,
OtoSCOPEW, for diagnosis of genetic hearing loss [3]. The
original design targeted 350,160 bp. We performed a sys-
tematic rebalancing of baits to improve on-target coverage,
increase coverage over poorly covered areas (increase bait
tiling), as well as decrease coverage variation among targets
(reduce bait tiling over highly covered regions). The reba-
lanced baits targeted 521,647 bp. Eight base-pair error-
correcting barcode sequences were adapted from another
study [16], see Supplementary Information for barcode
sequences, and no barcodes showed drop-out in our initial
experiments (data not shown). We performed TGE here
using liquid handling automation equipment (Bravo system,
Agilent Technologies) using SureSelect XT version 1 (post-
capture) or SureSelect XT version 2 (pre-capture 12 and
pre-capture 16) kits. All sequencing was performed on the
Illumina HiSeq 2000 using paired-end 76 bp reads with
96 samples sequenced per lane.
Bioinformatics analysis
Bioinformatics analysis was performed using a local installa-
tion of the Galaxy software and a custom analysis pipeline,
as previously described [3] with modifications. Briefly, read
mapping to the human reference genome (Hg19) was per-
formed using BWA [17]; duplicate reads were analyzed and
removed with Picard (http://picard.sourceforge.net); and
local realignment and variant identification was completed
with GATK [18]. We used a threshold of 4 sequencing
reads and required a variant to be present in ≥15% of reads
to be considered. Variants were compared against our data-
base of deafness variants (deafnessvariationdatabase.org).
Statistics were calculated using Samtools [19], Bedtools [20]
and NGSRich [21]. Copy number variants (CNVs) were
determined using a previously published method that nor-
malizes sequencing depth among samples, identifies out-
liers, and calls via a sliding-window method [22].
Additional files
Additional file 1: Table S1. Positive Control Mutations.
Additional file 2: Table S2. 8 bp barcodes used.
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